Express News | Changzhou Qianhong Biopharma: Plans to raise no more than 1 billion yuan for acquisition and technological transformation upgrades and other projects.

BreakingsNov 21 18:52

Changzhou Qianhong Biopharma (002550) company brief: significant profit growth, planning to acquire Fangyuan Pharmaceutical to expand product line.

Key investment points show a significant increase in net income and a continuous improvement in gross margin. In the first three quarters of 2024, the company achieved revenue of 1.208 billion yuan (-17.62%) and net income attributable to the parent company of 0.31 billion yuan (+56.47%), net of non-recurring gains or losses.

Donghai SecuritiesOct 22 15:31

Changzhou Qianhong Biopharma (002550.SZ): It is expected that the sales price of heparin active pharmaceutical ingredient will improve in the fourth quarter compared to the previous quarter.

Changzhou Qianhong Biopharma (002550.SZ) stated in an investor relations event on October 22nd that in the third quarter of 2024, the sales volume of heparin active pharmaceutical ingredient has significantly increased year-on-year, with gross profit and gross margin at historically high levels. However, despite this, export sales prices remain low, with no apparent significant fluctuations in foreign market demand. The slaughtering volume of pigs in 2024 decreased by about 10% year-on-year. It is expected that the sales price of heparin active pharmaceutical ingredient will improve in the fourth quarter compared to the third quarter, possibly showing a stable recovery trend.

Gelonghui FinanceOct 22 15:08

A-shares Changzhou Qianhong Biopharma hit the limit up.

October 18th, Gelonhui | Changzhou Qianhong Biopharma's bid rose by the daily limit, the company plans to acquire 100% equity of Fangyuan Pharmaceuticals for 0.39 billion yuan.

Gelonghui FinanceOct 18 09:27

Qianhong Pharmaceutical: Report for the third quarter of 2024

SZSIOct 18 00:00 · Announcements

Express News | Changzhou Qianhong Biopharma: plans to acquire 100% equity of Fangyuan Pharmaceutical for 0.39 billion yuan.

BreakingsOct 17 17:18